The Application of Evidence-Based Medicine in Individualized Medicine
/in International Publications, IOZK Veröffentlichungen /von 2023-06-23 / Biomedicines 2023 Jun;11(7)Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
/in Dendritic Cells, Glioblastoma, International Publications, Malignant Melanoma /von 2023-05-03 / Hum Vaccin Immunother 2023 May;:2198467Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
/in Dendritic Cells, Glioblastoma, International Publications /von 2023-04-21 / J Pharm Anal 2023 Jun;13(6):616-624Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2023-04-12 / Biomed Pharmacother 2023 Jun;162:114685Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2023-04-10 / Genes (Basel) 2023 Apr;14(4)Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment
/in International Publications, Newcastle Disease Virus /von 2023-04-04 / J Cancer Metastasis Treat 2023;9The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2023-04-03 / Pharmaceutics 2023 Apr;15(4)Personalized dendritic cell vaccination in cancer therapy: An evidence-based research study
/in Dendritic Cells, International Publications /von 2023-04-01 / J Cancer Res Ther 2023 Apr;19(Supplement):S52-S58Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2023-03-15 / Front Cell Infect Microbiol 2023;13:1142172
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de